Can-Fite Received IRB Approval for the Treatment of Pancreatic Cancer with Namodenoson in a Phase IIa Study

Download

• Small JPEG, 400x400, 32.0 KB
• Preview JPEG, 144x144, 9.3 KB
• Thumbnail JPEG, 70x70, 3.2 KB